Active Risk Levels Slashed Equities, Factors, Quant & Systematic, Risk and Regulation Super funds have slashed their active risk budgets in response to the YFYS performance test and the challenging market environment. This means funds have to be smarter about their remaining budget and avoid uncompensated risks, Northern Trust Asset Management says. Read More
Creating Value Through Engagement Equities, ESG Listed markets are facing some strong headwinds, but by applying proactive engagement with companies investors can realise significant returns over the long term, Tanarra’s Vidhur Rangaswamy says. Read More
The Importance of Top-down in EM Emerging Markets, Equities When investing in emerging markets, you can’t ignore the top-down, Janus Henderson’s Daniel Graña says. If you do, you might end up with some nasty surprises. Read More
The Respectful Activist Equities, Private & Alternative Markets Activism doesn’t have to be confrontational. Instead, acting as a trusted adviser to companies often achieves a more lasting re-rating of the share price, Tanarra’s Vidhur Rangaswamy says. Read More
Lessons from a Burst Bubble Equities, Financial Crisis Japan might not have fully recovered yet from the asset bubble burst of the 1980s, but this event provided some valuable lessons, some of which shape the investment decisions of Intermede’s Barry Dargan to this day. Read More
Inflation, Equities and Kryptonite Equities, MarketFox In this MarketFox column, we’ll explore the effects of high inflation on equities, what this means for equity investors and investors holding a “balanced” portfolio. Read More
AustralianSuper To Increase External Mandates Asset Owners, Equities AustralianSuper is committed to increase the amount of funds managed by external managers by 60 per cent to $80 billion. Read More
Fusion as a Source of Clean Energy Equities, Innovation Recent advances in laser technology have brought clean energy generation from nuclear fusion a step closer, Dr. Warren McKenzie says. This could see a dramatic impact on energy prices. Read More
Innovation in Healthcare Equities, Innovation The healthcare sector is at an inflection point, where decades of research is now starting to throw off innovative new therapies and treatments and this could very well lead to a ‘golden age’ for the sector, American Century Investments says. Read More
